RxDoctor Payments Data

Anthony Ricciardi, DPM

Podiatrist · Las Vegas, NVNPI 1629087242

Payments from drug & device makers

What this record shows

This record is dominated by ownership interests: $495,000 of the $498,164 with a category attached, or 99.4%. Paragon 28, Inc. accounts for 99.4% of it on its own, with 30 other manufacturers making up the rest. Reporting peaked in 2020 at $495,524 and has fallen 99.9% since, to $307 in 2025. Among podiatrist clinicians in NV with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$498,164in general payments, 2019–2025

Across 77 payments — averaging $6469.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Paragon 28, Inc.$495K
  • Treace Medical Concepts, Inc.$484
  • Nevro Corp.$273
  • Smith+Nephew$271
  • Zimmer Biomet$224
  • Arthrosurface Incorporated$220
  • plus $2K from 25 others

What the payments were for

  • Travel & lodging$70%
  • Food & beverage$3,1571%
  • Ownership interest$495,00099%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$498,164 in reported general payments places this provider in the 95th percentile of 44 podiatrist providers in Nevada.

See all podiatrist providers in Nevada

Medicare billing

Part B allowed, 2024
$128,533
Medicare patients
321
Services billed
3,090

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
CiclopiroxCiclopirox Olamine87$2,346
Ciclopirox58$1,805
Cephalexin39$235
Ibuprofen19$150
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen15$143
Terbinafine Hcl21$139
Mupirocin22$121
Doxycycline Hyclate12$83
Pantoprazole Sodium13$0

Paid to pharmacies, not to this prescriber.

Other podiatrist in Las Vegas

See the full list for Nevada

Where these figures come from

Is this you, or does something look wrong? →